These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 27703156)
1. Genome-wide compendium and functional assessment of in vivo heart enhancers. Dickel DE; Barozzi I; Zhu Y; Fukuda-Yuzawa Y; Osterwalder M; Mannion BJ; May D; Spurrell CH; Plajzer-Frick I; Pickle CS; Lee E; Garvin TH; Kato M; Akiyama JA; Afzal V; Lee AY; Gorkin DU; Ren B; Rubin EM; Visel A; Pennacchio LA Nat Commun; 2016 Oct; 7():12923. PubMed ID: 27703156 [TBL] [Abstract][Full Text] [Related]
2. Epigenomic and Transcriptomic Dynamics During Human Heart Organogenesis. VanOudenhove J; Yankee TN; Wilderman A; Cotney J Circ Res; 2020 Oct; 127(9):e184-e209. PubMed ID: 32772801 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive multi-omics integration identifies differentially active enhancers during human brain development with clinical relevance. Yousefi S; Deng R; Lanko K; Salsench EM; Nikoncuk A; van der Linde HC; Perenthaler E; van Ham TJ; Mulugeta E; Barakat TS Genome Med; 2021 Oct; 13(1):162. PubMed ID: 34663447 [TBL] [Abstract][Full Text] [Related]
5. Large-scale discovery of enhancers from human heart tissue. May D; Blow MJ; Kaplan T; McCulley DJ; Jensen BC; Akiyama JA; Holt A; Plajzer-Frick I; Shoukry M; Wright C; Afzal V; Simpson PC; Rubin EM; Black BL; Bristow J; Pennacchio LA; Visel A Nat Genet; 2011 Dec; 44(1):89-93. PubMed ID: 22138689 [TBL] [Abstract][Full Text] [Related]
6. Epigenomic model of cardiac enhancers with application to genome wide association studies. Sahu AD; Aniba R; Chang YP; Hannenhalli S Pac Symp Biocomput; 2013; ():92-102. PubMed ID: 23424115 [TBL] [Abstract][Full Text] [Related]
7. Epigenome overlap measure (EPOM) for comparing tissue/cell types based on chromatin states. Li WV; Razaee ZS; Li JJ BMC Genomics; 2016 Jan; 17 Suppl 1(Suppl 1):10. PubMed ID: 26817822 [TBL] [Abstract][Full Text] [Related]
8. Computational schemes for the prediction and annotation of enhancers from epigenomic assays. Whitaker JW; Nguyen TT; Zhu Y; Wildberg A; Wang W Methods; 2015 Jan; 72():86-94. PubMed ID: 25461775 [TBL] [Abstract][Full Text] [Related]
9. Effects of gene regulatory reprogramming on gene expression in human and mouse developing hearts. Hsu CH; Ovcharenko I Philos Trans R Soc Lond B Biol Sci; 2013; 368(1620):20120366. PubMed ID: 23650638 [TBL] [Abstract][Full Text] [Related]
10. GeneHancer: genome-wide integration of enhancers and target genes in GeneCards. Fishilevich S; Nudel R; Rappaport N; Hadar R; Plaschkes I; Iny Stein T; Rosen N; Kohn A; Twik M; Safran M; Lancet D; Cohen D Database (Oxford); 2017 Jan; 2017():. PubMed ID: 28605766 [TBL] [Abstract][Full Text] [Related]
11. Rapid and pervasive changes in genome-wide enhancer usage during mammalian development. Nord AS; Blow MJ; Attanasio C; Akiyama JA; Holt A; Hosseini R; Phouanenavong S; Plajzer-Frick I; Shoukry M; Afzal V; Rubenstein JL; Rubin EM; Pennacchio LA; Visel A Cell; 2013 Dec; 155(7):1521-31. PubMed ID: 24360275 [TBL] [Abstract][Full Text] [Related]